Loading clinical trials...

Knee Injections for Obese Patients With Knee Arthritis | Clinical Trials | Clareo Health

RECRUITINGPHASE4

Knee Injections for Obese Patients With Knee Arthritis

Comparison of Varying Doses of Steroid for Intra-articular Knee Injections

NCT06782529•Mayo Clinic

Summary

The purpose of this study is to assess obese patients with knee arthritis and determine the non-inferiority of a low dose steroid treatment vs. standard dose steroid treatment for two knee outcome measures: pain and function.

Eligibility

Age

55 - 85 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patients with BMI ≥30 kg/m2 and radiograph-proven knee osteoarthritis who are interested in receiving a steroid injection for knee arthritis.

Exclusion Criteria

•BMI \< 30 kg/m2
•Uncontrolled diabetics with a hemoglobin A1c \> 8%
•No other treatment within the time frame of the study.
•Patients that are undergoing physical therapy at the time of the study.

Locations (1)

Mayo Clinic in Florida

Jacksonville, Florida, United States

Key Dates

Start Date

January 24, 2025

Primary Completion Date

January 24, 2027

Completion Date

January 24, 2027

Last Updated

March 10, 2026

Enrollment

ESTIMATED participants

Conditions

Osteoarthritis of Knee

Interventions

Triamcinolone Acetonide Low Dose

DRUG

Triamcinolone Acetonide Standard Dose

DRUG

Contacts

Jeffrey P Nadwodny, DO

CONTACT

904 953 6722 nadwodny.jeffrey@mayo.edu

Cannabinoids for Osteoarthritis Pain Effectiveness Trial

NCT06878417

Osteoarthritis of KneeOsteoarthritis Hip

View study

RECRUITINGPHASE4

Concentrated Bone Marrow Aspirate in Revision ACL Reconstruction

NCT06311513

Anterior Cruciate Ligament InjuriesPost-Traumatic Osteoarthritis of Knee+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 10, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Knee Injections for Obese Patients With Knee Arthritis

Inclusion Criteria

Exclusion Criteria

Cannabinoids for Osteoarthritis Pain Effectiveness Trial

Concentrated Bone Marrow Aspirate in Revision ACL Reconstruction

A Phase 1/2a to Evaluate the Safety and Efficacy of Adipose Tissue Allograft (BRC-OA) in Patients With Osteoarthritis of the Knee

Computer-guided Action Planning to Support Physical Activity (CAPPA) for Employees with Chronic Knee Symptoms

RCT on the Performance and Safety of LightForce® Therapy Lasers on Knee Osteoarthritis Pain Reduction (SPARK)

Duloxetine As an Analgesic in Patients Without Central Sensitivity After Same Sitting Bilateral Total Knee Arthroplasty